An agreement between the Japan International Co-operation Agency (JICA) and the National Institute of Hygiene and Epidemiology and Pasteur Institute in Ho Chi Minh City establishes a level-3 biosafety laboratory at the Pasteur Institute to examine and manage hazardous infectious pathogens.
Identifying pathogens, knowing where and how they spread, as well as any treatments they could be resistant to are questions that must be answered for each disease outbreak.
This training includes a total of five courses which each review a component of the Laboratory Response Network (LRN) protocols for bioterrorism agent identification.
Researchers have developed a pathogen capture platform based on a genetically engineered version of a natural human blood protein.
The US Defense Advanced Research Projects Agency (DARPA) hopes to develop programmable microbes to produce medications on the fly.
The next use for sequencing technology is using it to understand gene expression changes in response to pathogen infection.